Ombrabulin
- CAS number
- 181816-48-8
- Application
- Ombrabulin is a combretastatin A-4 derivative that exerts its antitumor effect by disrupting the formation of blood vessels needed for tumor growth.
- Molecular weight
- 402.4409 g/mol
- Molecular formula
- C21H26N2O6
SOCOSUR OEL/OEB Risk Assessments are a quick and efficient way to obtain:
- Complete review of all relevant toxicological and medical databases as well as Material Safety Data Sheets and chemical books, in accordance with the regulations from National Institute for Occupational Safety and Health (NIOSH), Naumann and Safebridge
- A classification in four categories based on CLP Regulation and Naumann and Safebridge proposals
- A rational for NOAEL values selection
- Categorization for the specific work conditions
Benefits of such OEL/OEB Assessment
A 20 to 30 pages report signed by an European toxicological expert, optimized in case of Regulatory Body inspection, with all calculation details and all bibliographic references linked to these calculations, as well as all the development and results for the categorization of the product.